As autumn approaches and respiratory illness season returns, the FDA has quietly approved four updated COVID-19 vaccines formulated to address the XFG variant, now available at pharmacies nationwide. The approval follows a pattern of annual reformulation that has become as routine as the flu shot cycle, reflecting how profoundly the relationship between society and this virus has transformed since the emergency years. Where once vaccine news commanded collective attention and national mobilization, this milestone arrives in near-silence — a measure of both adaptation and the dispersal of share